Company Filing History:
Years Active: 2001-2003
Title: Oskar W Rokhlin: Innovator in Prostate Cancer Research
Introduction
Oskar W Rokhlin is a notable inventor based in Coralville, IA (US), recognized for his contributions to the field of prostate cancer research. With a total of 2 patents to his name, Rokhlin has made significant strides in developing targeted therapies for prostate cancer.
Latest Patents
Rokhlin's latest patents include the development of prostate cell surface antigen-specific antibodies. These antibodies bind to a protein found on both normal and cancerous prostate cells, while being absent on nonprostate cells. Additionally, he has disclosed a hybridoma that produces the antibody to the prostate-specific protein. Furthermore, his patents also cover antibodies that are conjugated to labels or cytotoxic moieties, enhancing their therapeutic potential.
Career Highlights
Oskar W Rokhlin is affiliated with the University of Iowa Research Foundation, where he continues to advance his research in cancer immunology. His work focuses on creating innovative solutions that can improve the diagnosis and treatment of prostate cancer.
Collaborations
Rokhlin has collaborated with esteemed colleagues such as George J Weiner and Michael B Cohen, contributing to a rich environment of research and innovation.
Conclusion
Oskar W Rokhlin's work in developing prostate cell surface antigen-specific antibodies represents a significant advancement in cancer research. His contributions are paving the way for more effective treatments for prostate cancer, showcasing the importance of innovation in medical science.